These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 39093319)

  • 1. Efficacy of anti-seizure medications and alternative therapies (ketogenic diet, CBD, and quinidine) in KCNT1-related epilepsy: A systematic review.
    Gras M; Bearden D; West J; Nabbout R
    Epilepsia Open; 2024 Aug; 9(4):1176-1191. PubMed ID: 39093319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KCNT1-related epilepsies and epileptic encephalopathies: phenotypic and mutational spectrum.
    Bonardi CM; Heyne HO; Fiannacca M; Fitzgerald MP; Gardella E; Gunning B; Olofsson K; Lesca G; Verbeek N; Stamberger H; Striano P; Zara F; Mancardi MM; Nava C; Syrbe S; Buono S; Baulac S; Coppola A; Weckhuysen S; Schoonjans AS; Ceulemans B; Sarret C; Baumgartner T; Muhle H; Portes VD; Toulouse J; Nougues MC; Rossi M; Demarquay G; Ville D; Hirsch E; Maurey H; Willems M; de Bellescize J; Altuzarra CD; Villeneuve N; Bartolomei F; Picard F; Hornemann F; Koolen DA; Kroes HY; Reale C; Fenger CD; Tan WH; Dibbens L; Bearden DR; Møller RS; Rubboli G
    Brain; 2021 Dec; 144(12):3635-3650. PubMed ID: 34114611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KCNT1-related epilepsy: An international multicenter cohort of 27 pediatric cases.
    Borlot F; Abushama A; Morrison-Levy N; Jain P; Puthenveettil Vinayan K; Abukhalid M; Aldhalaan HM; Almuzaini HS; Gulati S; Hershkovitz T; Konanki R; Lingappa L; Luat AF; Shafi S; Tabarki B; Thomas M; Yoganathan S; Alfadhel M; Arya R; Donner EJ; Ehaideb SN; Gowda VK; Jain V; Madaan P; Myers KA; Otsubo H; Panda P; Sahu JK; Sampaio LPB; Sharma S; Simard-Tremblay E; Zak M; Whitney R
    Epilepsia; 2020 Apr; 61(4):679-692. PubMed ID: 32167590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to cannabidiol in epilepsy of infancy with migrating focal seizures associated with KCNT1 mutations: An open-label, prospective, interventional study.
    Poisson K; Wong M; Lee C; Cilio MR
    Eur J Paediatr Neurol; 2020 Mar; 25():77-81. PubMed ID: 31926846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy.
    Dilena R; DiFrancesco JC; Soldovieri MV; Giacobbe A; Ambrosino P; Mosca I; Galli MA; Guez S; Fumagalli M; Miceli F; Cattaneo D; Darra F; Gennaro E; Zara F; Striano P; Castellotti B; Gellera C; Varesio C; Veggiotti P; Taglialatela M
    Neurotherapeutics; 2018 Oct; 15(4):1112-1126. PubMed ID: 30112700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KCNT1-positive epilepsy of infancy with migrating focal seizures successfully treated with nonnarcotic antitussive drugs after treatment failure with quinidine: A case report.
    Takase C; Shirai K; Matsumura Y; Watanabe T; Watanabe A; Hirasawa-Inoue A; Mizuguchi T; Matsumoto N; Sugai K; Hayashi M
    Brain Dev; 2020 Sep; 42(8):607-611. PubMed ID: 32505479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two Patients With KCNT1-Related Epilepsy Responding to Phenobarbital and Potassium Bromide.
    Datta AN; Michoulas A; Guella I; ; Demos M
    J Child Neurol; 2019 Oct; 34(12):728-734. PubMed ID: 31208268
    [No Abstract]   [Full Text] [Related]  

  • 8. Purified Cannabidiol for Treatment of Refractory Epilepsies in Pediatric Patients with Developmental and Epileptic Encephalopathy.
    Pietrafusa N; Ferretti A; Trivisano M; de Palma L; Calabrese C; Carfì Pavia G; Tondo I; Cappelletti S; Vigevano F; Specchio N
    Paediatr Drugs; 2019 Aug; 21(4):283-290. PubMed ID: 31179531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment Responsiveness in KCNT1-Related Epilepsy.
    Fitzgerald MP; Fiannacca M; Smith DM; Gertler TS; Gunning B; Syrbe S; Verbeek N; Stamberger H; Weckhuysen S; Ceulemans B; Schoonjans AS; Rossi M; Demarquay G; Lesca G; Olofsson K; Koolen DA; Hornemann F; Baulac S; Rubboli G; Minks KQ; Lee B; Helbig I; Dlugos D; Møller RS; Bearden D
    Neurotherapeutics; 2019 Jul; 16(3):848-857. PubMed ID: 31054119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of response to quinidine in KCNT1-related neonatal epilepsy.
    Numis AL; Nair U; Datta AN; Sands TT; Oldham MS; Patel A; Li M; Gazina E; Petrou S; Cilio MR
    Epilepsia; 2018 Oct; 59(10):1889-1898. PubMed ID: 30182418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KCNT1 epilepsy with migrating focal seizures shows a temporal sequence with poor outcome, high mortality and SUDEP.
    Kuchenbuch M; Barcia G; Chemaly N; Carme E; Roubertie A; Gibaud M; Van Bogaert P; de Saint Martin A; Hirsch E; Dubois F; Sarret C; Nguyen The Tich S; Laroche C; des Portes V; Billette de Villemeur T; Barthez MA; Auvin S; Bahi-Buisson N; Desguerre I; Kaminska A; Benquet P; Nabbout R
    Brain; 2019 Oct; 142(10):2996-3008. PubMed ID: 31532509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New use for an old drug: quinidine in KCNT1-related epilepsy therapy.
    Liu R; Sun L; Wang Y; Wang Q; Wu J
    Neurol Sci; 2023 Apr; 44(4):1201-1206. PubMed ID: 36437393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Anti-seizure Medications, Quinidine, and Ketogenic Diet Therapy for
    Lin Z; Sang T; Yang Y; Wu Y; Dong Y; Ji T; Zhang Y; Wu Y; Gao K; Jiang Y
    Front Neurol; 2021; 12():834971. PubMed ID: 35116000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular characterization of
    McTague A; Nair U; Malhotra S; Meyer E; Trump N; Gazina EV; Papandreou A; Ngoh A; Ackermann S; Ambegaonkar G; Appleton R; Desurkar A; Eltze C; Kneen R; Kumar AV; Lascelles K; Montgomery T; Ramesh V; Samanta R; Scott RH; Tan J; Whitehouse W; Poduri A; Scheffer IE; Chong WKK; Cross JH; Topf M; Petrou S; Kurian MA
    Neurology; 2018 Jan; 90(1):e55-e66. PubMed ID: 29196579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision therapy with quinidine of KCNT1-related epileptic disorders: A systematic review.
    Xu D; Chen S; Yang J; Wang X; Fang Z; Li M
    Br J Clin Pharmacol; 2022 Dec; 88(12):5096-5112. PubMed ID: 35940594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches for the discovery of drugs that target K Na 1.1 channels in KCNT1-associated epilepsy.
    Miziak B; Czuczwar SJ
    Expert Opin Drug Discov; 2022 Dec; 17(12):1313-1328. PubMed ID: 36408599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis and EEG markers of KCNT1 epilepsy of infancy with migrating focal seizures.
    Kuchenbuch M; Benquet P; Kaminska A; Roubertie A; Carme E; de Saint Martin A; Hirsch E; Dubois F; Laroche C; Barcia G; Chemaly N; Milh M; Villeneuve N; Sauleau P; Modolo J; Wendling F; Nabbout R
    Epilepsia; 2019 Jan; 60(1):20-32. PubMed ID: 30525185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quinidine non responsive novel KCNT1 mutation in an Indian infant with epilepsy of infancy with migrating focal seizures.
    Madaan P; Jauhari P; Gupta A; Chakrabarty B; Gulati S
    Brain Dev; 2018 Mar; 40(3):229-232. PubMed ID: 29037447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic and clinical analysis of children with early-onset epilepsy encephalopathy caused by KCNT1 gene mutation].
    Chen Y; Bao XH; Zhang QP; Wang JP; Wen YX; Yu SJ; Zhao Y
    Zhonghua Er Ke Za Zhi; 2018 Nov; 56(11):824-828. PubMed ID: 30392206
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.